-
1.发明授权公开(公告)号：US06962926B2
公开(公告)日：2005-11-08
申请号：US10637746
申请日：2003-08-08
申请人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Wenli Ma , Yukiharu Matsumoto , Kunihisa Baba , Hideaki Inagaki , Katsumasa Tanaka , Yoshiro Ishiwata , Shoji Yokochi , Masayuki Okamoto , Takashi Nakamura , Atsushi Miyachi , Mitsuaki Takeuchi , Kouji Matsushima
发明人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Wenli Ma , Yukiharu Matsumoto , Kunihisa Baba , Hideaki Inagaki , Katsumasa Tanaka , Yoshiro Ishiwata , Shoji Yokochi , Masayuki Okamoto , Takashi Nakamura , Atsushi Miyachi , Mitsuaki Takeuchi , Kouji Matsushima
IPC分类号： A61K31/437 , A61K31/496 , A61K31/5377 , A61K31/5513 , A61K45/06 , A61P29/00 , C07D471/04 , C07D498/04 , C07D519/00 , C61K31/5377
CPC分类号： A61K31/437 , A61K9/0019 , A61K9/2054 , A61K9/4866 , A61K31/496 , A61K31/5377 , A61K31/5513 , A61K45/06 , C07D231/56 , C07D471/04 , A61K2300/00
摘要： Compounds of formula A and formula B: and their pharmaceutically acceptable salts, compositions comprising them, methods for their use, and their use in the preparation of medicaments. The compounds are antagonists of MCP-1 function, and are useful in the prevention and treatment of chronic or acute inflammatory or autoimmune diseases, such as multiple sclerosis, and in the prevention and treatment of allergic hypersensitivity disorders.
摘要翻译： 式A和式B化合物及其药学上可接受的盐，包含它们的组合物，其使用方法及其在制备药物中的用途。 该化合物是MCP-1功能的拮抗剂，可用于预防和治疗慢性或急性炎性或自身免疫性疾病如多发性硬化，以及预防和治疗过敏性超敏反应性疾病。
-
公开(公告)号：US06809113B2
公开(公告)日：2004-10-26
申请号：US10087208
申请日：2002-02-27
申请人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
发明人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
IPC分类号： A61K3135
CPC分类号： C07D401/12 , C07D215/48 , C07D241/42 , C07D265/36 , C07D319/18 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12
摘要： Compounds which are antagonists of MCP-1 function and are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection; pharmaceutical compositions comprising these compounds; and the use of these compounds and compositions in the prevention or treatment of such diseases.
摘要翻译： 作为MCP-1拮抗剂的化合物起作用，可用于预防或治疗慢性或急性炎性或自身免疫性疾病，特别是与异常淋巴细胞或单核细胞积累相关的疾病如关节炎，哮喘，动脉粥样硬化，糖尿病性肾病，炎性肠病， 克罗恩病，多发性硬化，肾炎，胰腺炎，肺纤维化，牛皮癣，再狭窄和移植排斥反应; 包含这些化合物的药物组合物; 以及这些化合物和组合物在预防或治疗这些疾病中的用途。
-
公开(公告)号：US06998407B2
公开(公告)日：2006-02-14
申请号：US10716652
申请日：2003-11-18
申请人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
发明人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
IPC分类号： A61K31/36 , A61K31/343 , C07D307/79 , C07D317/60
CPC分类号： C07D235/06 , C07D209/08 , C07D249/18 , C07D263/56 , C07D307/79 , C07D317/68 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12
摘要： Chemical compounds which are antagonists of Monocyte Chemoattractant Protein-1 (MCP-1) function, pharmaceutical compositions comprising these compounds, methods of treatment employing these compounds and compositions, and processes for preparing these compounds. The compounds are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection.
摘要翻译： 作为单核细胞趋化蛋白-1（MCP-1）功能拮抗剂的化合物，包含这些化合物的药物组合物，使用这些化合物和组合物的治疗方法，以及制备这些化合物的方法。 该化合物可用于预防或治疗慢性或急性炎性或自身免疫疾病，特别是与异常淋巴细胞或单核细胞积累相关的疾病，如关节炎，哮喘，动脉粥样硬化，糖尿病性肾病，炎性肠病，克罗恩病，多发性硬化，肾炎， 胰腺炎，肺纤维化，牛皮癣，再狭窄和移植排斥。
-
公开(公告)号：US06992086B2
公开(公告)日：2006-01-31
申请号：US10716363
申请日：2003-11-17
申请人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
发明人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
IPC分类号： A61K31/496 , A61K31/437 , C07D498/04 , C07D471/04 , A61P37/00
CPC分类号： C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5377 , A61K31/5513 , A61K45/06 , A61K2300/00
摘要： The present invention relates to chemical compounds, pharmaceutical compositions comprising said compounds, uses of said compounds and compositions, methods of treatment employing said compounds and compositions, and processes for preparing said compounds. Specifically, this invention relates to novel compounds which are antagonists of MCP-1 function and are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection. More specifically, the invention is related to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases.
-
公开(公告)号：US06677365B2
公开(公告)日：2004-01-13
申请号：US10106881
申请日：2002-03-25
申请人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
发明人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
IPC分类号： A61K3142
CPC分类号： C07D235/06 , C07D209/08 , C07D249/18 , C07D263/56 , C07D307/79 , C07D317/68 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12
摘要： Chemical compounds which are antagonists of Monocyte Chemoattractant Protein-1 (MCP-1) function, pharmaceutical compositions comprising these compounds, methods of treatment employing these compounds and compositions, and processes for preparing these compounds. The compounds are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection.
-
公开(公告)号：US07297696B2
公开(公告)日：2007-11-20
申请号：US10969440
申请日：2004-10-19
申请人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
发明人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
IPC分类号： A61K31/498 , C07D241/36
CPC分类号： C07D401/12 , C07D215/48 , C07D241/42 , C07D265/36 , C07D319/18 , C07D405/12 , C07D407/12 , C07D409/12 , C07D417/12
摘要： Compounds which are antagonists of MCP-1 function and are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephrtitis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection; pharmaceutical compositions comprising these compounds; and the use of these compounds and compositions in the prevention or treatment of such diseases.
摘要翻译： 作为MCP-1拮抗剂的化合物起作用，可用于预防或治疗慢性或急性炎性或自身免疫性疾病，特别是与异常淋巴细胞或单核细胞积累相关的疾病如关节炎，哮喘，动脉粥样硬化，糖尿病性肾病，炎性肠病， 克罗恩病，多发性硬化，肾炎，胰腺炎，肺纤维化，牛皮癣，再狭窄和移植排斥反应; 包含这些化合物的药物组合物; 以及这些化合物和组合物在预防或治疗这些疾病中的用途。
-
公开(公告)号：US06670364B2
公开(公告)日：2003-12-30
申请号：US10060967
申请日：2002-01-29
申请人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
发明人： Edgardo Laborde , Louise Robinson , Fanying Meng , Brian T. Peterson , Hugo O. Villar , Steven E. Anuskiewicz , Yoshiro Ishiwata , Shoji Yokochi , Yukiharu Matsumoto , Takuji Kakigami , Hideaki Inagaki , Takahito Jomori , Kouji Matsushima
IPC分类号： A61P2900
CPC分类号： C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5377 , A61K31/5513 , A61K45/06 , A61K2300/00
摘要： The present invention relates to chemical compounds, pharmaceutical compositions comprising said compounds, uses of said compounds and compositions, methods of treatment employing said compounds and compositions, and processes for preparing said compounds. Specifically, this invention relates to novel compounds which are antagonists of MCP-1 function and are useful in the prevention or treatment of chronic or acute inflammatory or autoimmune diseases, especially those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, Crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis, and transplant rejection. More specifically, the invention is related to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases.
摘要翻译： 本发明涉及化合物，包含所述化合物的药物组合物，所述化合物和组合物的用途，使用所述化合物和组合物的治疗方法，以及制备所述化合物的方法。 具体而言，本发明涉及作为MCP-1功能的拮抗剂的新化合物，其可用于预防或治疗慢性或急性炎性或自身免疫性疾病，特别是与异常淋巴细胞或单核细胞积累相关的疾病，例如关节炎，哮喘，动脉粥样硬化， 糖尿病肾病，炎性肠病，克罗恩病，多发性硬化，肾炎，胰腺炎，肺纤维化，牛皮癣，再狭窄和移植排斥反应。 更具体地，本发明涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗这些疾病中的用途。
-
公开(公告)号：US08093231B2
公开(公告)日：2012-01-10
申请号：US11779234
申请日：2007-07-17
申请人： David R. Allen , Wenli Ma , Brian T. Peterson , Louise Robinson , Steven R. Schow , Songyuan Shi , Reyna J. Simon , Kevin T. Weber , Michael M. Wick
发明人： David R. Allen , Wenli Ma , Brian T. Peterson , Louise Robinson , Steven R. Schow , Songyuan Shi , Reyna J. Simon , Kevin T. Weber , Michael M. Wick
CPC分类号： C07F9/2458 , C07F9/2408 , C07F9/572 , C07F9/58 , C07F9/59 , C07F9/650952 , C07F9/6533 , C07F9/65515 , C07F9/655345 , C07F9/65616
摘要： Sulfonylethyl and thioethyl phosphorodiamidates, their preparation and intermediates in their preparation, formulations containing them, and their pharmaceutical use. The compounds are useful for treating cancer, alone and in combination with other anticancer therapies.
摘要翻译： 磺基乙基和硫代乙基磷酰二胺，它们的制备和中间体在制备中，含有它们的制剂及其药物用途。 该化合物可用于单独治疗和与其它抗癌疗法组合治疗癌症。
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.063 秒)
